Enteral feeding tube Market Size, Share, Growth, and Industry Analysis, By Type (gastrostomy tube,Nasointestinal canal,other), By Application (Oncology Department,Gastroenterology,Neurology,Diabetes,other), Regional Insights and Forecast to 2035

Enteral feeding tube Market Overview

The global Enteral feeding tube Market size is projected to grow from USD 3152.63 million in 2026 to USD 3301.12 million in 2027, reaching USD 4789.69 million by 2035, expanding at a CAGR of 4.71% during the forecast period.

The global enteral feeding tube market was valued at US$ 2.5 billion in 2023. The nasoenteric feeding tube segment generated approximately US$ 1.7 billion, highlighting its dominance. The cancer (oncology) segment accounted for 48% of global enteral feeding tube application share in 2023. Polyurethane material tubes held about 55.2% of material-based share globally in 2024. The gastrostomy tube type led with 47.5% share among tube types in 2023, showing preference for long-term solutions. These figures reflect strong demand driven by chronic diseases and nutritional support requirements.

The United States held 74.3% of the North America feeding tubes market in 2024. Each year, the U.S. performs over 230,000 percutaneous endoscopic gastrostomy (PEG) placements. Around 15 million people in the country live with swallowing disorders that necessitate enteral feeding support. In 2023, North America’s enteral feeding tube market was valued at US$ 876.2 million, with the U.S. contributing the largest portion. Hospitals remain the leading end-use setting, while home care use is growing significantly among pediatric and geriatric groups.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Key Market Driver: Cancer accounted for 48% of disease-condition segment in 2023.
• Major Market Restraint: Short-term feeding tubes (< 4 weeks) represented 58.7% of tube type usage.
• Emerging Trends: Home care feeding captured the leading end-use share, surpassing 50% globally.
• Regional Leadership: North America held 38.3% of global market share in 2023.
• Competitive Landscape:S. firms represented 83% of North America’s market in 2024.
• Market Segmentation: Gastrostomy tubes had 47.5% share; oncology applications held 41.7%.
• Recent Development: Polyurethane tubes led materials with 55.2% share in 2024.

Enteral feeding tube Market Latest Trends

The Enteral feeding tube Market is shifting towards safer, durable, and patient-friendly devices. In 2023, nasoenteric feeding tubes represented 68% of market revenue, equal to US$ 1.7 billion out of US$ 2.5 billion. Gastrostomy tubes accounted for 47.5% share among tube types, reflecting growing use for long-term patients with neurological and swallowing disorders. Polyurethane material dominated in 2024 with 55.2% share due to better biocompatibility, flexibility, and reduced blockage rates compared to PVC. In applications, oncology led with 41.7% of demand, followed by gastroenterology and neurology. Short-term usage (< 4 weeks) remained common, comprising 58.7% of total placements in 2023. The home care segment has emerged as a leading end-use, surpassing hospitals and projected to grow beyond 50% of total market use in coming years. In North America, regional dominance was clear with 38.3% share of the global market, while the U.S. captured 74.3% of the North America market. Emerging regions, especially Asia-Pacific, are gaining momentum with increasing awareness and growing malnutrition burdens. Enteral feeding tube Market Trends underline the importance of oncology care, material innovations, and the shift toward decentralized home-based enteral nutrition.

Enteral feeding tube Market Dynamics

DRIVER

"Aging population & chronic disease burden"

In 2023, cancer represented 48% of the global enteral feeding tube demand, making oncology the leading driver. The global geriatric population continues to grow, with over 74 million adults aged 65+ projected in North America by 2030. Stroke, dementia, and Alzheimer’s are increasing, causing feeding difficulties. Hospitals and ICUs rely heavily on feeding tubes, with short-term devices accounting for 58.7% of usage. This demand underpins Enteral feeding tube Market Growth worldwide.

RESTRAINT

"Complications and care variability"

Complications such as infection, clogging, and dislodgement impact up to 30% of feeding tube placements. In the U.S., about 22% of insurance claims for advanced or replacement tubes are denied. Frequent replacements are required since short-term tubes dominate at 58.7% share. These issues restrain adoption, particularly in resource-limited settings.

OPPORTUNITY

"Expansion of home care and pediatric demand"

Home care has emerged as a strong opportunity, representing over 50% of end-use share globally. Approximately 15 million premature infants are born annually, many requiring tube feeding. Polyurethane tubes, with a 40% lower occlusion rate than PVC, highlight opportunities for innovation and adoption in outpatient and pediatric care.

CHALLENGE

"Regulatory and reimbursement barriers"

Medical device regulations in Europe and North America are increasingly stringent, slowing new product launches. Reimbursement challenges lead to 22% claim denials in North America. Limited awareness in developing regions prevents broader adoption, despite strong clinical need. Regional disparities in care highlight ongoing market challenges.

Enteral feeding tube Market Segmentation

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

BY TYPE

Gastrostomy tubes: Gastrostomy tubes held 47.5% of the global market share in 2023, making them the leading product type. These tubes are primarily used in long-term feeding, especially for patients with chronic neurological conditions, stroke recovery, and head and neck cancers. In the U.S. alone, more than 230,000 percutaneous endoscopic gastrostomy (PEG) procedures are performed annually. Their dominance reflects the need for permanent or semi-permanent feeding access, particularly among elderly patients and those with dysphagia.

Gastrostomy tube segment size is estimated at USD 1,655.78 million in 2025, representing 55.0% share of the market and growing at an estimated 4.50% CAGR.

Top 5 Major Dominant Countries in the Gastrostomy tube Segment

• United States: Market size approximately USD 579.02 million, share 35.0% of the gastrostomy segment, with an expected CAGR of 4.4%.
• China: Market size approximately USD 331.16 million, share 20.0%, with an expected CAGR of 5.2% due to rising clinical adoption.
• United Kingdom: Market size approximately USD 281.49 million, share 17.0%, with an expected CAGR of 4.1% supported by established hospital networks.
• Japan: Market size approximately USD 264.92 million, share 16.0%, with an expected CAGR of 3.9% reflecting aging population demand.
• Germany: Market size approximately USD 198.19 million, share 12.0%, with an expected CAGR of 4.0% driven by procedural volumes.

Nasointestinal tubes: Nasogastric, nasojejunal, and nasoduodenal tubes accounted for about 68% of total revenue in 2023, generating nearly US$ 1.7 billion. They are mostly used for short-term feeding, typically less than four weeks, and are widely applied in intensive care units (ICUs) and emergency care. The short-term usage segment overall comprised 58.7% of global demand in 2023, with nasoenteric tubes as the largest contributor.

Nasointestinal canal segment size is estimated at USD 903.15 million in 2025, representing 30.0% share of the market and growing at an estimated 5.20% CAGR.

Top 5 Major Dominant Countries in the Nasointestinal canal Segment

• United States: Market size approximately USD 270.95 million, share 30.0%, with an expected CAGR of 5.0% driven by acute-care usage.
• China: Market size approximately USD 225.79 million, share 25.0%, with an expected CAGR of 5.8% due to expanding hospital capacity.
• India: Market size approximately USD 162.57 million, share 18.0%, with an expected CAGR of 6.0% reflecting improving access to therapy.
• Germany: Market size approximately USD 126.44 million, share 14.0%, with an expected CAGR of 4.6% from steady clinical adoption.
• Japan: Market size approximately USD 117.40 million, share 13.0%, with an expected CAGR of 4.2% supported by specialized care centers.

Other tubes: This category includes jejunostomy, gastrojejunostomy (GJ), and low-profile button tubes, representing roughly 30–35% of the market when combined. These tubes are crucial for pediatric patients, preterm infants, and adults who cannot tolerate gastric feeding due to aspiration risk or gastroparesis. Their use is expanding in metabolic and neonatal care, especially in regions with high premature birth rates.

Other enteral feeding tubes segment size is estimated at USD 451.58 million in 2025, representing 15.0% share of the market and growing at an estimated 3.80% CAGR.

Top 5 Major Dominant Countries in the Other Segment

• United States: Market size approximately USD 126.44 million, share 28.0%, with an expected CAGR of 3.7% from niche product uptake.
• China: Market size approximately USD 99.35 million, share 22.0%, with an expected CAGR of 4.1% as alternative devices gain traction.
• Brazil: Market size approximately USD 81.29 million, share 18.0%, with an expected CAGR of 3.9% supported by expanding private care.
• France: Market size approximately USD 76.77 million, share 17.0%, with an expected CAGR of 3.5% due to steady institutional demand.
• Australia: Market size approximately USD 67.73 million, share 15.0%, with an expected CAGR of 3.6% from growing community care services.

BY APPLICATION

Oncology: Oncology was the largest application segment in 2023, holding 41.7% share of the global market. Head and neck cancer patients, along with gastrointestinal cancer cases, rely heavily on enteral feeding tubes during chemotherapy and radiotherapy, when swallowing difficulties become severe.

Oncology application size is estimated at USD 903.15 million in 2025, representing 30.0% share and growing at about 5.00% CAGR.

Top 5 Major Dominant Countries in the Oncology Application

• United States: Oncology application size approximately USD 316.07 million, share 35.0%, CAGR 4.9%, driven by high cancer treatment volumes.
• China: Oncology application size approximately USD 180.63 million, share 20.0%, CAGR 5.7%, reflecting expanding oncology services.
• Japan: Oncology application size approximately USD 135.47 million, share 15.0%, CAGR 4.2%, linked to specialized clinical programs.
• Germany: Oncology application size approximately USD 108.38 million, share 12.0%, CAGR 4.3%, from established oncology centers.
• United Kingdom: Oncology application size approximately USD 62.60 million, share 6.9%, CAGR 4.1%, reflecting protocol-driven feeding use.

Gastroenterology: Gastroenterology accounted for a significant portion of demand, with an estimated 30–35% share of the global market. Disorders like Crohn’s disease affect nearly 3 million people in the United States and Europe, while ulcerative colitis impacts another 2 million. Gastroparesis, a condition commonly seen in both diabetic and non-diabetic populations, affects about 10 million individuals globally. These conditions frequently require nasojejunal or jejunostomy feeding tubes, particularly in acute hospital care. As a result, gastroenterology remains one of the top three applications for enteral feeding worldwide.

Gastroenterology application size is estimated at USD 1,053.68 million in 2025, representing 35.0% share and growing at approximately 4.80% CAGR.

Top 5 Major Dominant Countries in the Gastroenterology Application

• United States: Gastroenterology size approximately USD 368.78 million, share 35.0%, CAGR 4.7%, driven by high procedure volumes.
• China: Gastroenterology size approximately USD 210.74 million, share 20.0%, CAGR 5.3%, from expanding endoscopy services.
• India: Gastroenterology size approximately USD 126.44 million, share 12.0%, CAGR 5.8%, due to rising clinical infrastructure.
• Germany: Gastroenterology size approximately USD 105.37 million, share 10.0%, CAGR 4.4%, reflecting established care pathways.
• Japan: Gastroenterology size approximately USD 84.29 million, share 8.0%, CAGR 4.0%, from aging-population needs.

Neurology: Neurological conditions like ALS, Parkinson’s disease, and dementia drive strong adoption. In the U.S., approximately 1 million Parkinson’s patients live with swallowing disorders, and nearly 80% of them require long-term enteral feeding. This creates a sustained demand for gastrostomy tubes in neurology.

Neurology application size is estimated at USD 451.58 million in 2025, representing 15.0% share and growing at approximately 4.00% CAGR.

Top 5 Major Dominant Countries in the Neurology Application

• United States: Neurology size approximately USD 158.55 million, share 35.1%, CAGR 3.9%, driven by chronic neurological care settings.
• Japan: Neurology size approximately USD 63.73 million, share 14.1%, CAGR 3.8%, reflecting long-term care demand.
• Germany: Neurology size approximately USD 54.19 million, share 12.0%, CAGR 3.7%, from rehabilitation centers.
• China: Neurology size approximately USD 50.70 million, share 11.2%, CAGR 4.3%, as specialized neurology units expand.
• United Kingdom: Neurology size approximately USD 43.47 million, share 9.6%, CAGR 3.6%, from integrated care pathways.

Diabetes: Diabetes contributed a smaller yet important segment of the market, representing 5–7% of global demand. Around 537 million adults worldwide are living with diabetes, and complications like diabetic gastroparesis occur in approximately 30–40% of patients with long-standing disease. This translates into millions of cases where enteral feeding becomes necessary to manage nutritional needs, particularly in advanced stages. The use of feeding tubes in diabetes-related care is most prominent in North America and Asia-Pacific, where prevalence rates are highest.

Diabetes application size is estimated at USD 301.05 million in 2025, representing 10.0% share and growing at approximately 4.50% CAGR.

Top 5 Major Dominant Countries in the Diabetes Application

• United States: Diabetes application size approximately USD 120.42 million, share 40.0%, CAGR 4.3% given high chronic-care focus.
• China: Diabetes application size approximately USD 60.21 million, share 20.0%, CAGR 5.0% reflecting rising diabetic population.
• India: Diabetes application size approximately USD 36.13 million, share 12.0%, CAGR 5.5% due to increasing clinical interventions.
• Germany: Diabetes application size approximately USD 24.08 million, share 8.0%, CAGR 4.0%, from integrated diabetes management programs.
• Brazil: Diabetes application size approximately USD 18.06 million, share 6.0%, CAGR 4.2%, supported by growing outpatient care.

Other: Globally, more than 15 million preterm infants are born annually, many requiring feeding tubes due to immature swallowing reflexes. Pediatric applications are rising rapidly, particularly in Asia-Pacific, where malnutrition remains a challenge and neonatal intensive care is expanding.

Other clinical applications combined are estimated at USD 301.05 million in 2025, representing 10.0% share and growing at approximately 3.90% CAGR.

Top 5 Major Dominant Countries in the Other Application

• United States: Other applications size approximately USD 90.32 million, share 30.0%, CAGR 3.8%, driven by diverse specialty uses.
• China: Other applications size approximately USD 60.21 million, share 20.0%, CAGR 4.2%, as new indications emerge.
• Brazil: Other applications size approximately USD 45.16 million, share 15.0%, CAGR 3.9%, from private-clinic adoption.
• France: Other applications size approximately USD 30.11 million, share 10.0%, CAGR 3.6%, reflecting targeted clinical programs.
• Australia: Other applications size approximately USD 18.06 million, share 6.0%, CAGR 3.7%, supported by community care expansion.

Enteral feeding tube Market Regional Outlook

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

NORTH AMERICA

North America dominated with 38.3% of global market share in 2023. The U.S. accounted for 74.3% of the regional market in 2024. Short-term feeding tubes made up 58.3% of usage, while gastric tubes represented 42.3% of the region’s product mix. Polyurethane material held 38.2% of North American demand in 2024 due to its lower occlusion rates. Strong healthcare infrastructure and high chronic disease prevalence make North America the market leader.

North America market size is estimated at USD 1,083.78 million in 2025, representing 36.0% share of the global market and exhibiting an estimated 4.20% CAGR.

North America - Major Dominant Countries in the Enteral feeding tube Market

• United States: Market size approximately USD 962.52 million, share 88.8% of North America, CAGR 4.2%, led by hospital adoption and reimbursement frameworks.
• Canada: Market size approximately USD 86.70 million, share 8.0%, CAGR 3.9%, supported by public health systems.
• Mexico: Market size approximately USD 21.68 million, share 2.0%, CAGR 4.6%, from improving acute-care infrastructure.
• Guatemala: Market size approximately USD 6.50 million, share 0.6%, CAGR 4.0%, reflecting nascent specialized services.
• Costa Rica: Market size approximately USD 6.38 million, share 0.6%, CAGR 4.1%, driven by private clinical centers.

EUROPE

Europe contributed approximately 25–30% of the global market. The region benefits from public healthcare systems that cover PEG placements and long-term enteral nutrition. By 2050, nearly 30% of Europe’s population will be aged 65+, driving demand for feeding tubes. Oncology and neurology are the leading applications, while regulatory frameworks such as MDR ensure high device safety standards.

Europe market size is estimated at USD 842.94 million in 2025, representing 28.0% share of the global market and exhibiting an estimated 4.50% CAGR.

Europe - Major Dominant Countries in the Enteral feeding tube Market

• Germany: Market size approximately USD 168.59 million, share 20.0% of Europe, CAGR 4.3%, due to strong hospital networks.
• United Kingdom: Market size approximately USD 151.66 million, share 18.0%, CAGR 4.1%, from established clinical protocols.
• France: Market size approximately USD 117.21 million, share 13.9%, CAGR 3.8%, reflecting broad institutional demand.
• Italy: Market size approximately USD 100.13 million, share 11.9%, CAGR 4.0%, driven by regional care centers.
• Spain: Market size approximately USD 88.51 million, share 10.5%, CAGR 3.9%, from growing specialty services.

ASIA-PACIFIC

Asia-Pacific accounted for about 20–30% of the market, representing the fastest-growing region. Around 70% of the world’s malnourished children are located here, and rising cancer prevalence in China, India, and Japan is boosting adoption. Hospital demand has risen sharply, with some countries reporting over 30% increases in enteral nutrition cases. Pediatric applications are particularly strong due to the region’s high number of premature births.

Asia market size is estimated at USD 903.15 million in 2025, representing 30.0% share of the global market and exhibiting an estimated 5.30% CAGR.

Asia - Major Dominant Countries in the Enteral feeding tube Market

• China: Market size approximately USD 270.95 million, share 30.0% of Asia, CAGR 5.8%, owing to expanding hospital capacity and demand.
• Japan: Market size approximately USD 162.57 million, share 18.0%, CAGR 4.2%, from an aging population.
• India: Market size approximately USD 135.47 million, share 15.0%, CAGR 6.0%, from improving access and adoption.
• South Korea: Market size approximately USD 81.29 million, share 9.0%, CAGR 4.5%, driven by specialty centers.
• Australia: Market size approximately USD 72.87 million, share 8.1%, CAGR 3.6%, supported by community and hospital care.

MIDDLE EAST & AFRICA

The enteral feeding tube market in the Middle East & Africa accounted for approximately US$ 175.5 million in 2023, which represented around 4.1% of the global market value. Within this region, the enteral feeding pump segment dominated with nearly 44.8% of the total revenue share in 2023, reflecting strong reliance on pumps for accurate delivery of enteral nutrition. Low-profile gastrostomy devices are emerging as the fastest-growing category, driven by rising use in pediatric and long-term care patients who benefit from discreet, comfortable feeding solutions.

Middle East & Africa market size is estimated at USD 180.63 million in 2025, representing 6.0% share of the global market and exhibiting an estimated 3.50% CAGR.

Middle East and Africa - Major Dominant Countries in the Enteral feeding tube Market

• Saudi Arabia: Market size approximately USD 49.36 million, share 27.3% of MEA, CAGR 4.0%, driven by healthcare investment.
• United Arab Emirates: Market size approximately USD 36.12 million, share 20.0%, CAGR 4.2%, from private-sector expansion.
• South Africa: Market size approximately USD 27.09 million, share 15.0%, CAGR 3.4%, reflecting tertiary-care centers.
• Egypt: Market size approximately USD 18.06 million, share 10.0%, CAGR 3.2%, from expanding regional services.
• Nigeria: Market size approximately USD 12.04 million, share 6.7%, CAGR 3.0%, supported by urban hospital growth.

List of Top Enteral feeding tube Companies

• Cook Medical
• Braun
• R. Bard
• Cardinal Health
• Fresenius Kabi
• Boston Scientific
• Vygon
• Halyard Health
• Nestle
• Conmed
• Danone
• Applied Medical
• Abbott

Abbott Laboratories: Key player, part of U.S. firms controlling 83% of the North America market.

Fresenius Kabi: Global leader with extensive portfolio, strong presence in oncology and nutrition-integrated devices.

Investment Analysis and Opportunities

The Enteral feeding tube Market Size reached US$ 2.5 billion in 2023, with North America alone valued at US$ 876.2 million. Developed regions like the U.S. offer mature demand, while Asia-Pacific presents rapid expansion due to aging populations, cancer, and malnutrition prevalence. Approximately 15 million premature infants are born globally each year, creating opportunities for pediatric feeding tubes. Polyurethane tubes, which hold 55.2% of global share, are investment targets for material innovation. Home care feeding already surpasses 50% global usage, valued at US$ 2.3 billion in projections, showing strong commercial potential. Companies innovating with antimicrobial coatings, sensor-enabled placement verification, and reduced occlusion designs can capture larger shares. Regulatory navigation and reimbursement advocacy also present opportunities for companies to differentiate and expand access.

New Product Development

Product development in the Enteral feeding tube Industry focuses on reducing complications and improving patient outcomes. Smart tubes with placement sensors are reducing dislodgement, an issue affecting up to 30% of tubes in some settings. Polyurethane-based products cut occlusion rates by about 40% compared to PVC. Low-profile button gastrostomy tubes are increasingly used in pediatrics for comfort and discreetness. Antimicrobial coatings are under development to reduce infection risks, which account for 12% of healthcare-associated infections in long-term care. Bluetooth-enabled feeding pumps and tubes for home care are entering the market, reflecting the growing home care share of over 50% globally. Reverse-balloon and tri-funnel G-tubes are new innovations that improve sealing and make replacements easier. These innovations align with Enteral feeding tube Market Insights that highlight a shift to safer, patient-centric devices.

Five Recent Developments

• Polyurethane tubes reached 55.2% share globally in 2024.
• Nasoenteric tubes generated US$ 1.7 billion in 2023, 68% of the total market.
• Short-term tubes (< 4 weeks) accounted for 58.7% of usage in 2023.
• Oncology applications led with 41.7% share in 2023.
• Gastric tubes comprised 42.3% of North America usage in 2024.

Report Coverage of Enteral feeding tube Market

The Enteral feeding tube Market Research Report covers product types such as gastrostomy, nasogastric, nasojejunal, jejunostomy, and gastrojejunostomy tubes. Applications include oncology, gastroenterology, neurology, diabetes, pediatric, and others. Materials covered include polyurethane, silicone, and PVC. Regional segmentation spans North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America. The Enteral feeding tube Market Analysis provides historical data (2018–2023), current market size (2023–2024), and forecasts to 2030. Key insights include market share by type (gastrostomy 47.5%), application (oncology 41.7%), material (polyurethane 55.2%), and regional distribution (North America 38.3%). Coverage extends to hospitals vs home care usage, with home care surpassing 50% share globally. The Enteral feeding tube Industry Report also evaluates competitive landscape, identifying Abbott and Fresenius Kabi as leaders. Report coverage highlights drivers like rising cancer prevalence, restraints like 30% complication rates, opportunities in pediatrics and home care, and challenges with 22% insurance denial rates. The Enteral feeding tube Market Outlook emphasizes innovations, investments, regulatory dynamics, and application growth.

Enteral feeding tube Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 3152.63 Million in 2026
Market Size Value By	USD 4789.69 Million by 2035
Growth Rate	CAGR of 4.71% from 2026 - 2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : gastrostomy tube Nasointestinal canal other By Application : Oncology Department Gastroenterology Neurology Diabetes other
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample